Advertisement

Meeting Coverage

SABCS 2020: Updates on Phase 3 PENELOPE-B

The collaborative Phase 3 PENELOPE-B will be presented at SABCS 2020. No unexpected safety signals were observed. Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free survival (iDFS) in...

Read More
Advertisement